Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelastine nasal spray plus saline for prevention of sinusitis in ICU patients with nasogastric tubes
IRCT20190312043037N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azelastine and sodium chloride in rhinosinusitis (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoint: Incidence of sinusitis confirmed by imaging. Started Sep 2017; status: completed.
02
Drugs
azelastinesodium chloride
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on IRCT20190312043037N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190312043037N1.